In contrast, mice that lacked one copy of LKB1 in the endometrium (Sprr2f-Cre; Lkb1L/+) were weakly susceptible to endometrial cancer, with one out of 12 mice developing a focal endometrial tumor at ~600 days old [23]. Here, SPRR2F is linked to endometrium neoplasm.